| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |